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ABSTRACT
CCAAT/enhancer binding proteins (C/EBP) are a family of tran-
scription factors with a highly conserved basic/leucine zipper (bZIP)
domain that has been implicated in the transcriptional control of
genes involved in cell growth and differentiation. We have previously
demonstrated that the expression of C/EBPa and C/EBPb genes is
regulated by thyroid hormone in rat liver during development. The
aim of the present study was to explore the molecular mechanisms
underlying the control of C/EBPa gene expression by thyroid hor-
mone. To achieve this goal, we isolated and characterized a genomic
clone containing 1171 bp of the 59-flanking region of the rat C/EBPa
gene. This fragment was an active promoter in MB492 cells, an im-
mortalized brown adipocyte cell line that expresses the endogenous
C/EBPa gene in a T3-dependent manner. Sequence analysis sug-
gested the presence of three thyroid hormone response elements,
TRE-1 (2602/2589), TRE2 (2411/2396), and TRE3 (2376/2350).
The results of deletion, mutagenesis, and gel mobility shift analysis
disclosed that only TRE-1, an ER2-type response element, repre-
sented a functional T3 response element. Our results demonstrate
that T3 is a factor that positively regulates C/EBPa gene expression
in a direct fashion. (Endocrinology 141: 4164–4170, 2000)
THE CCAAT/ENHANCER-BINDING proteins are afamily of transcription factors that contain a leucine
zipper motif required for dimer formation and a basic DNA-
binding domain that facilitates interactions between these
factors and the regulatory sequences of promoters and/or
enhancers of target genes (1, 2). They are involved in the
regulation of cell proliferation, differentiation (3–5), and en-
ergy metabolism (6). The C/EBPa gene was the first member
of the family to be cloned and contains two major in-frame
translation start sites and consequently generates two pro-
teins of 42 and 30 kDa (7, 8). Liver and fat are the major tissues
where this gene is expressed, and overexpression of C/EBPa
in preadipocytes inhibits cell proliferation (5) and activates
genes characteristic of differentiated fat cells (3, 9, 10). Con-
versely, C/EBPa antisense RNA blocks terminal differenti-
ation of preadipocytes, indicating that this gene is essential
for adipocyte differentiation (11). In the liver, the C/EBPa
protein plays a central role in energy metabolism and reg-
ulates the transcription of a number of metabolically impor-
tant genes, such as 422/aP2, phosphoenolpyruvate car-
boxykinase (PEPCK), and fatty acid synthase (12). The
important role of C/EBPa in fat and liver development is
clearly shown in knockout mice. These animals have a major
reduction in the lipid content of the fat tissue (6), do not store
hepatic glycogen, and die from hypoglycemia within 8 h after
birth (6). Also, studies with primary hepatocytes from these
C/EBPa-deficient mice suggest that this protein influences
proliferation, differentiation, and cell survival in liver (6, 13).
Thyroid hormone (T3) is an important regulator of growth,
differentiation, and metabolic processes (14). The primary
site of initiation of T3 action resides in the nucleus, where the
interaction of this hormone with specific nuclear receptors
can either enhance or repress the rate of transcription of
responsive genes. Thyroid hormone receptors (TRs) are tran-
scription factors that belong to the superfamily of nuclear
receptors, which also includes, among others, retinoic acid,
steroids, and vitamin D receptors (15). T3 receptors are en-
coded by two distinct genes, TRa (NR1A1) and TRb
(NR1A2). Alternative splicing of the TRa primary transcripts
at their 39-extremity generates messenger RNAs (mRNAs)
encoding TRa1, which binds T3, as well as the variants TRa2
and TRa3, which do not. Alternative promoters and splicing
generate two T3-binding isoforms, TRb1 and TRb2 (16). TR
activities are mediated through binding to specific DNA
elements, called thyroid hormone response elements (TREs),
that are present in the promoter of target genes. They are
composed of two hexameric half-sites closely related to the
consensus AGGTCA, arranged either as direct repeats or as
palindromic or everted (ER) palindromic arrays (17, 18).
The control of C/EBPa gene expression is poorly under-
stood. It is known that C/EBPa is developmentally regulated
in liver and adipose tissue (19, 20). Also, C/EBPa mRNA has
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been shown to be regulated by insulin and glucocorticoids in
vivo (21, 22), and more recently we reported the regulation of
this gene by thyroid hormone (T3) and retinoic acid during
liver development (19). Therefore, to clarify the mechanism
of T3 regulation of the C/EBPa gene, we have isolated, se-
quenced, and studied the biological activity of a genomic frag-
ment encoding 1171 bp of the 59-flanking region of the C/EBPa
gene. Our results show that thyroid hormone activates tran-
scription from the C/EBPa promoter. Functional analysis by
transient transfection of different 59-flanking region fragments
as well as gel mobility shift assays and mutagenic analysis
suggest that the T3 effect is mediated through a functional TRE
located between nucleotides (nt) 2602 and 2589 (TRE-1),
which is an ER2-type response element.
Materials and Methods
Genomic library screening and promoter constructs
A rat genomic library in bacteriophage lt10 (Stratagene, La Jolla, CA)
was screened with a 32P-labeled 400-bp fragment of the 59-region of the
mouse C/EBPa promoter. Duplicate filters were hybridized using stan-
dard conditions previously reported (23). Phage plaques that hybridized
positively were identified and plaque-purified by secondary and tertiary
screening procedures. Two clones were isolated, and one clone con-
taining a 9.0-kb insert was chosen for further analysis. An approximately
1.2 fragment extending from nt 21171 to 123 was sequenced by the
dideoxynucleotide chain termination method in an Applied Biosystem
377 sequencer (Foster City, CA), amplified by PCR, and subcloned into
TA-cloning vector (Invitrogen, Groningan, The Netherlands). The am-
plified 21171/123 fragment was sequenced again to exclude any pos-
sible mutation.
The 1.2-kb fragment was subcloned in the luciferase reporter vector
pXP-1 (pCEBP1171). The 59-deletions of C/EBPa promoter, 2689/123
(pCEBPD689), 2587/123 (pCEBPD587), and 2380/123 (pCEBPD380),
were generated by PCR and subcloned into the pXP-1-luc vector, and the
39-deletions, 2689/2290 (pCEBPD290) and 2689/2220 (pCEBPD220),
were subcloned in the pT109-luc plasmid upstream of the thymidine
kinase promoter (2105/15).
Point mutations of the TRE-1 site in the 21171/123 fragment were
created by PCR using the DNA polymerase PfuTurbo following the
instructions of the QuickChange site-directed mutagenesis method
(Stratagene). The sequences of the oligonucleotides (coding strand) used
for mutagenesis are as follows (mutated nucleotides are underlined):
MUT1, 59-GTA GTG GGG TCG ATA TCA GTT CAG AGA TAA-39;
MUT2, 59-GGG GTC GCC TGG CA GCT GAG ATA AAG ACG-39;
MUT3, 59-GTA GTG GGG TCG ATT GGA TAT CAG AGA TAA-39;
MUT4, 59-GGG GTC GCC TGT GAG TTC AGA GAT-39; MUT5, 59-GGG
TCG CCT GTC GAG TTC AGA GAT-39; MUT6, 59-GGG GTC GCC TGA
GTT CAG AGA T-39; and MUT7, 59-TGG GGT CGC CTA GTT CAG
AGA T-39.
The PCR product was digested with DpnI, and the DpnI-treated DNA
was transformed into DH5a competent cells. Plasmids carrying inserts
of the appropriate size were sequenced in both directions.
Cell culture and transfections
MB492 cells were maintained in DMEM (Life Technologies, Inc.,
Grand Island, NY) supplemented with 10% FBS. Semiconfluent cells
were transiently transfected using Lipofectamine (Life Technologies,
Inc.) according to the manufacturer’s guidelines. Briefly, 105 cells were
plated on 3.5-cm tissue culture dishes in DMEM containing 10% FBS and
after 24 h were transfected with the different constructions of the
C/EBPa promoter. Typically, cells received 2 mg luciferase reporter
plasmid and 2 mg of an internal control plasmid, pCMVbgal, which
contains the gene for b-galactosidase enzyme. After 8 h of exposure to
the Lipofectamine/DNA mixture, the cells were incubated in complete
medium for another 18 h. Cells were then washed, incubated in serum-
free medium containing, or not, T3 (100 nm), and harvested after 24 h for
determination of b-galactosidase and luciferase activities as previously
described (23). Quantification of luciferase activity was performed with
a Berthlod-BioLumat luminometer Beethold GmBH & Co., Bad Wildbad,
Germany. Each transient transfection experiment was repeated at least
three times in triplicate.
Protein preparation and gel mobility assays
To generate the rat TRb1, the complementary DNA containing the
coding region of this protein was amplified by PCR and subcloned into
the BamHI and BglII sites of pQE16, which introduces a histidine tag on
the C-terminus (pQE16 vectors; QIAGEN, Hilden, Germany). The his-
tidine-tagged receptor was expressed in the XL1-Blue Escherichia coli
strain. After induction for 1.5 h with 0.1 mm isopropylthio-b-d-galac-
toside (IPTG), the histidine-tagged TRb1 was purified. Human RXRa
protein was generated by expressing pGEX-RXR in NM522 E. coli strain
and, after induction with 0.1 mm IPTG, was purified using glutathione-
Sepharose 4B (Amersham Pharmacia Biotech, Europe, GmbH, Freiburg,
Germany). For the binding reactions, 2 mg purified TRb1 and RXR
proteins were preincubated for 10 min at room temperature in a buffer
containing 15 mm HEPES (pH 8.4), 60 mm KCl, 1 mm EDTA, 1 mm
dithiothreitol, 5 mm MgCl2, 12% glycerol, and 2 mg poly(dI-dC) in a total
volume of 20 ml. After a further 20-min incubation at room temperature
in the presence of 60,000 cpm labeled probes, the complexes were sep-
arated by electrophoresis on a 5% native polyacrylamide gel. In com-
petition assays, nonradioactive double stranded oligonucleotides were
added to the reaction mixture in a 100-fold excess of the radioactive
probe. To perform supershift analysis, anti-TRb1 antibody was added
to the reaction mixture and incubated for an additional 15 min. The
oligonucleotides used for the assays were as follows (complementary
strands are not shown): site TRE-1, 59-GTA GTG GGG TCG CCT GGA
GTT CAG AGA TAA-39 (2611/2582); site TRE-2, 59-CAC GGT AGC
TCA AGA CTA ACA TCC TC-39 (2417/2392); and site TRE-3, 59-CCC
CCA ACC TTC ACC TCC CCT TGC TCG GCC TCT GGA TG-39
(2380/2343).
Northern blot analysis
Total RNA was extracted by homogenization in guanidinium thio-
cyanate as previously described (24). Twenty micrograms of RNA were
electrophoresed on a 2.2 m formaldehyde/1% agarose gel in 1 3 MOPS
{20 mm MOPS 5 (3[N-morpholino]propane-sulfonic acid; 1 mm EDTA;
50 mm sodium acetate; 90 mm NaOH)} buffer at 100 V for 3–4 h and
transferred to nylon membranes (Nytran, Renner, Darmstadt, Germa-
ny). Labeled C/EBPa probe (.108 cpm/mg) was generated using ran-
dom primers and [32P]deoxy-CTP (3000 Ci/mmol) and hybridized with
the membranes for 20 h at 42 C (50% formamide, 3 3 SSC, and 0.2% SDS).
The washing conditions were 2 3 SSC and 0.5% SDS at 65 C for mild
washing and 0.2 3 SSC and 0.5% SDS at 65 C for stringent washing.
Methylene blue staining of the membranes was used as a loading con-
trol. Values in the text are the average quantification of at least three
independent experiments corresponding to three different samples.
RT-PCR analysis
Two micrograms of total RNA from MB492 cells were reverse tran-
scribed at 42 C for 1 h with 0.5 mg of the corresponding reverse primer
and 9 U avian myeloblastosis virus reverse transcriptase (Promega
Corp., Madison, WI) in 20 ml of the PCR buffer [20 mm Tris-HCl, 16 mm
(NH4)2SO4, 2.5 mm MgCl2, and 0.15 mg/ml BSA, pH 8.55]. After inac-
tivation of the reverse transcriptase (65 C, 10 min), PCR was performed
using 2 ml of the reaction mixture and 2.5 U Taq polymerase (PE Bio-
systems) for 25 cycles (94 C for 1 min, 55 C for 1 min, 72 C for 2 min,
and a final extension at 72 C for 7 min) in a final volume of 50 ml. Aliquots
of the PCR reaction were analyzed by electrophoresis through 0.8%
agarose gel and visualized with ethidium bromide. The oligode-
oxynucleotides used for PCR amplification were as follows: rat TRa1
(forward primer, 59-GAG GAT CCA TGG AAC AGA AGC CAA GCA
AG-39; reverse primer, 59-GAA GAT CTG ACT TCC TGA TCC TCA
AAG AC-39) that will amplify a fragment of 1200 bp (nt 354-1554) and
rat TRb1 (forward primer, 59-GAA GAT CTA TGA CAG AAA ATC GCC
TTC CA-39; reverse primer, 59-GAA GAT CTG TCC TCA AAG ACT TCC
AAG AAG-39) that will amplify a fragment of 1300 bp (nt 236-1636).
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Statistical analysis
The data were analyzed using the StatWorks software package. Sig-
nificant effects were determined using Student’s t test. A statistically
significant difference was considered at P # 0.05.
Results
Endogenous C/EBPa gene expression is regulated by T3 in
MB492 cells
Regulation of C/EBPa gene promoter activity was ana-
lyzed in an immortalized brown adipocyte cell line (MB492).
This cell line was originally obtained by cotransfection of
brown adipocytes obtained from 21-day-old Wistar rat fe-
tuses with immortalizing simian virus 40 large T antigen and
pMEXneo. This cell line maintains specific properties of
brown adipocytes, such as expression of the uncoupling pro-
tein as well as expression of several adipose genes, including
the C/EBP family of proteins (25).
Most of the established cell lines lose their thyroid hor-
mone receptors; therefore, we performed RT-PCR analysis to
determine whether MB492 cells express TRa1 and TRb1. As
shown in Fig. 1A, MB492 cells express appreciable amounts
of both isoforms (the identities of the PCR products were
confirmed by sequence analysis). The functionality of these
receptors was checked by analyzing the effect of T3 on the
expression of the endogenous C/EBPa gene. To this end, T3
was added to the culture medium of MB492 cells, and at
different times after hormone addition, cells were harvested
and C/EBPa mRNA levels were measured by Northern blot
analysis. After treatment with 100 nm T3 for 2 and 24 h,
C/EBPa mRNA increased 3.5 6 0.7- and 3.6 6 0.5-fold,
respectively, compared with that in untreated controls (Fig.
1B). Therefore, this cell line constitutes an excellent model to
study the molecular mechanisms implicated in the regula-
tion of the C/EBPa gene by thyroid hormone.
Cloning and expression of C/EBPa promoter
A 1.2-kb fragment of the 59-flanking promoter region of the
C/EBPa gene, was cloned by screening a lgt10 rat genomic
library and was subsequently sequenced bidirectionally by
the Sanger method using sequential oligonucleotides as
primers. Computer analysis of this 59-flanking sequence re-
vealed several consensus sequences for known regulatory
elements, including a TATA box beginning at position 226,
an Sp1 binding site (2150/2143), and binding sites for par-
ticular transcription factors, such as C/EBP (2194/2185),
cAMP response element (21056/21049), nerve growth fac-
tor I-A (NGFI-A; 2262/2254), and Oct-1 (2790/2778). This
fragment contains also three potential thyroid hormone re-
sponse elements at nucleotides 2602 to 2589 (TRE-1), 2411
to 2396 (TRE-2), and 2376 to 2350 (TRE-3; Fig. 2).
To determine the biological activity of C/EBPa promoter,
several fragments of the C/EBPa promoter were cloned up-
stream of the luciferase reporter gene in the pXP1 vector
(constructs pCEBP1171, pCEBPD689, pCEBPD587, and
pCEBPD380) or in the pT109 plasmid, containing a minimal
promoter of the thymidine kinase (constructs pCEBPD290
and pCEBPD220), and tested for their expression in MB492
cells. Basal activities are shown in Fig. 3A. Transfection of the
pCEBP1171 construct in MB492 cells led to a modest level of
luciferase activity (assigned a relative value of 1). Deletion of
482 bp from the 59-end of this fragment resulted in 100-fold
enhancement of the activity obtained with the bigger con-
struct, suggesting the removal of a negative element. Dele-
tion of a region between 2689 and 2587 (construct
pCEBPD587) again reduced the activity slightly, whereas
removal of nucleotides between 2587 and 2380 (construct
pCEBPD380) elevated the basal activity to an extent closely
similar to that of the pCEBPD689 construct. These data sug-
gest the presence of strong negative and positive cis-elements
along the C/EBPa gene promoter.
To identify the location of TREs in rat C/EBPa promoter,
we next analyzed the responses to thyroid hormone of all of
these constructs. The results are shown in Fig. 3, B and C. The
fragment 21171/123 (construct pCEBP1171) conferred
maximal responsiveness to T3 (3-fold the basal value). The
response to T3 decreased with the plasmid containing the
region 2689/123 (construct pCEBPD689). No T3 stimulation
of luciferase activity was observed with constructs
pCEBPD587 and pCEBPD380. The constructs pCEBPD290
and pCEBPD220 (Fig. 3C) conferred a 2-fold T3 inducibility
to the thymidine kinase promoter, indicating that the regions
2689/2290 and 2689/2220 can confer T3 responsiveness to
a heterologous promoter. All of these data together suggest
that the fragment 2689/2587 is the one that mediates reg-
ulation by T3, and that sequences downstream or upstream
of this fragment are not required for induction by this hor-
mone. These results would rule out a functional role of pu-
tative TRE-2 (2411 to 2396) and TRE-3 (2376 to 2350) in
mediating the regulation of C/EBPa gene promoter by T3.
Analysis of receptor binding to TRE-1, TRE-2, and TRE-3
To determine whether the three potential response ele-
ments of the C/EBPa gene were able to bind TR, we per-
formed gel mobility shift assays with recombinant receptors
and oligonucleotides containing TRE-1, TRE-2, and TRE-3
sequences, and the complexes formed resolved in a native
acrylamide gel. The results presented in Fig. 4 show that
FIG. 1. Regulation of rat endogenous C/EBPa gene expression by
thyroid hormone. A, RT-PCR analysis. TRb1 and TRa1 were ampli-
fied from MB492 cells using the specific oligonucleotides described in
Materials and Methods. Amplified products were electrophoresed
through agarose gels and stained with ethidium bromide. L, Ladder.
B, Analysis of endogenous levels of C/EBPa transcripts. Total RNA
was extracted from MB492 cells 2 and 24 h after addition of T3, and
Northern studies were performed with a specific C/EBPa-labeled
probe as indicated in Materials and Methods. A representative North-
ern blot is shown. C, Membranes were stained with methylene blue
for the RNA loading control.
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TRE-2 and TRE-3 are able to specifically bind TRb1 receptor;
however, these receptors bind to these sites only as mono-
mers. The retarded bands were supershifted by a TRb1-
specific antibody, confirming the presence of this receptor.
On the contrary, when RXR was added to the reaction mix-
ture, only TRE-1 was able to specifically bind TR/RXR het-
erodimers. The retarded bands were competed with unla-
beled TRE-containing oligonucleotides. In most of the cases
known to date, it is thought that the functional T3-responsive
element binds TRs as heterodimers with RXR proteins.
Therefore, as neither TRE-2 nor TRE-3 was able to bind
TR/RXR heterodimers, although they do bind the TRb1 re-
ceptor, these results further suggest that the only functional
TRE in the C/EBPa promoter is TRE-1.
Mutagenesis analysis
To further confirm our findings about the functional role
of TRE-1 in regulating activation of the C/EBPa promoter by
T3, we generated several point mutation, insertion, and de-
letion constructs, using the QuickChange site-directed mu-
tagenesis (see Materials and Methods) and examined their
ability to confer T3 responsiveness (Fig. 5). The constructs
were then transfected into MB492 cells, and luciferase activ-
ity was measured 24 h after addition of T3. Mutations in either
of the half-sites of TRE-1 totally eliminated C/EBPa-TRE-1
function (MUT1-MUT3). Addition of one nucleotide (MUT4) or
deletion of one (MUT6) or two nucleotides (MUT7) in the spac-
ing region between the half-sites also prevented the 3-fold in-
crease in response to T3. However, addition of two nucleotides
to this spacing region, and therefore changing the response
element to an everted repeat separated by four nucleotides
(MUT5, ER4), did not abrogate the response to T3 of C/EBPa
promoter. These results combined with the data from the de-
letion and band-shift analysis indicate that TRE-1 is the func-
tional T3-responsive element in this promoter.
Discussion
The results reported here extend our previous findings
concerning the regulation by thyroid hormone of C/EBPa
gene expression in liver. In this paper we show that the
FIG. 2. Nucleotide sequence of the 59-
flanking region of the rat C/EBPa gene.
The TATA box is indicated in bold let-
tering. Sequences homologous to bind-
ing sites for transcription factors and
TREs are identified above the sequence.
GenBank database under Accession No.
AF208520.
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C/EBPa gene promoter contains a TRE within its 59-flanking
region that appears to mediate the induction of C/EBPa gene
expression by T3 via interaction with TR/RXR heterodimers.
Our earlier studies showed a complex regulation of
C/EBPa gene expression by T3 (19). Discrepancies in the
kinetics of C/EBPa transcripts and protein accumulation in
response to T3 in hypothyroid neonates prompted us to pos-
tulate a translational and/or posttranslational mechanism of
regulation of this gene by thyroid hormone. However, and
in contrast to hypothyroid animals, the injection of T3 to
euthyroid neonates elicited a very rapid increase in C/EBPa
mRNA levels (unpublished results from our laboratory),
suggesting the existence of a direct transcriptional mecha-
nism. This possibility is reinforced by the rapid response of
the C/EBPa gene to T3 in MB492 cells. Here we have cloned
1171 bp of the C/EBPa promoter region and characterized its
regulation by thyroid hormone.
First, we studied the basal activity of the C/EBPa pro-
moter and, in agreement with Rana et al. (26), we found that
this promoter has strong positive and negative cis-acting
elements. The induction of luciferase activity with constructs
pCEBPD689 and pCEBPD380 strongly suggests the existence
of two potent silencer elements in the regions 21171/2689
and 2587/2380. In addition, the decrease in luciferase ac-
tivity obtained with the construct pCEBPD587 points to the
existence of a strong positive element between 2689 and
2587. The presence of such elements is relatively common in
other promoters (27, 28).
Sequence analysis of the promoter region located between
nucleotides 21171 and 123 revealed the presence of three po-
tential TR-binding sites: TRE-1 (2602/2589, TCGCCTggAGT-
TCA), which resembles the TR-binding site referred to as an
everted repeat with two nucleotides of separation between the
two hexamers: TGACCTnnAGGTCA; TRE-2 (2411/2396),
which resembles a TRE of the type everted repeat with an
spacing of three nucleotides; and TRE-3 (2376/2350), which is
similar to a composite site, containing several core motifs found
in the PEPCK promoter (29). All of our data indicate that only
TRE-1 is responsible for the induction of C/EBPa gene pro-
moter by T3. Serial deletions mapped the boundaries of the
FIG. 3. Activation of rat C/EBPa pro-
moter by T3. A, Basal activities of dif-
ferent regions of rat C/EBPa promoter.
The different constructs shown at the
left were transiently transfected into
MB492 cells, and luciferase assays were
performed 24 h after transfections.
Data are expressed relative to the val-
ues obtained with the bigger fragment
(21171/123), and represent the
mean 6 SD luciferase activity deter-
mined in triplicate in at least three in-
dependent experiments. B, Identifica-
tion of DNA regions mediating the
regulation by T3 of C/EBPa promoter
activity. MB492 cells were transiently
transfected with luciferase reporter
plasmids containing 59-deletions of the
C/EBPa promoter, and luciferase activ-
ity was determined after 24 h of incu-
bation in the presence or absence of T3.
Data are expressed relative to the basal
value and represent the mean 6 SD of
luciferase activity determined in tripli-
cate in at least three independent ex-
periments. C, Same as B, but using re-
porter plasmids containing 39-deletions
of the C/EBPa promoter linked to a het-
erologous promoter. *, P # 0.05; **, P #
0.01; ***, P # 0.001.
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elements required for T3 induction of C/EBPa promoter activ-
ity to the interval between nucleotides 2689 and 2587, and
consequently, only the constructs pCEBP1171 and pCEBPD689
respond to T3 in the transfection experiments. Point mutations
in either of the half-sites of the palindromic sequence of the
TRE-1 abolished trans-activation, indicating that these two
modules play a primary role in C/EBPa-TRE-1 function. Only
MUT5, with four nucleotides forming the spacing region, in-
stead of two, was also responsive to T3. Gel mobility shift assays
demonstrate that the only sequence bound with high affinity by
TR/RXR heterodimers is the one that includes the TRE-1 ele-
ment. This sequence is unable to bind the receptor monomers;
this suggests that the heterodimer is the molecular element that
mediates thyroid hormone action. To our knowledge, the TRE-1
of the C/EBPa gene promoter is the first ER2 proposed as a
positive TRE in a native promoter. Previously, ERs with 6 nt of
spacing also have been found to be positive TREs in natural
promoters such as the promoters of the chicken lysozyme and
rat myelin basic protein genes (30, 31). In the case of the chicken
lysozyme promoter, the TRE is part of the core nuclei of a
silencer sequence, but, as indicated, this element elicits a pos-
itive response to thyroid hormone. Elements of the palindromic
type seem to be less common, but synthetic versions of such
sites confer potent T3 responses.
Also, the C/EBPa promoter has binding sites for other
transcription factors, such as C/EBP (2194/2185) and
NGFI-A (2262/2254), which mediate their actions on this
gene (32–34). Both transcription factors, C/EBP and NGFI-A,
have been shown to interfere with T3 induction (29, 35, 36)
of other genes. Our results showed that the removal of these
binding sites (constructs pCEBPD290 and pCEBPD220) did
not affect the inductive effect of T3 on C/EBPa promoter,
suggesting that the effect of thyroid hormone is independent
of the actions of C/EBP and NGFI-A proteins.
Both factors, C/EBPa and thyroid hormone, are involved
in the regulation of carbohydrate and lipid metabolism in
liver and adipose tissue, mainly through the regulation of genes
involved in these processes. C/EBPa has been implicated in the
transcriptional activation of several genes, such as PEPCK,
acetyl-coenzyme A carboxylase, Glut 4, insulin receptor, and
FIG. 4. Gel retardation analysis of
TRb1 and RXR binding to different
regions of the C/EBPa promoter. Re-
combinant TRb1 and RXR proteins
were incubated with radiolabeled oligo-
nucleotides encompassing the TRE-1,
TRE-2, and TRE-3 sequences, and
DNA-protein complexes were visual-
ized on 5% nondenaturing acrylamide
gels. The mobilities of the TR monomers
and TR/RXR heterodimers are indi-
cated by arrowheads. Arrows mark the
positions of the complexes after super-
shifting. Competition experiments were
carried out in the presence of a 100-fold
excess of the same unlabeled oligonu-
cleotides.
FIG. 5. Mutation and deletion analysis
of C/EBPa promoter TRE-1. Wild-type
and mutant promoter constructs were
transfected into MB492 cells. Transfec-
tion studies were performed as de-
scribed in Fig. 3. Data are expressed
relative to the basal values and repre-
sent the mean 6 SD luciferase activity
determined in triplicate in at least three
independent experiments. **, P # 0.01;
***, P # 0.001.
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stearoyl-CoA desaturase 1 (9, 10, 29, 37, 38). Many of these genes
are also regulated by thyroid hormone, such as PEPCK, acetyl-
coenzyme A carboxylase (38, 39), and Glut4 (40, 41). In addition,
and as we have commented previously, it has been shown that
the C/EBP-binding sites present in the promoters of PEPCK
and S14 are required for T3 stimulation of these genes (29, 35).
Therefore, our findings showing a transcriptional regulation of
C/EBPa gene by T3 could represent an important mode of
action of thyroid hormone on carbohydrate and lipid metab-
olism in liver and adipose tissue.
In summary, this report describes a direct transcriptional
regulation of C/EBPa gene expression by T3. This effect
requires a TRE that binds TR/RXR heterodimers, is located
between nucleotides 2602/2589, and resembles an everted
repeat with two nucleotides of separation (ER2). However,
taking into account the results obtained in vivo (19), non-
transcriptional mechanisms cannot be ruled out. Therefore,
it seems that in this particular gene, transcriptional and post-
transcriptional mechanisms act in concert to amplify the
effect of thyroid hormone.
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